Revvity | PKI - Assets


Revvity reported $11.49B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Align Technology USD 6.52B 103.03M Sep/2026
Bio Techne USD 2.59B 36.12M Jun/2026
Bio-Rad Laboratories USD 10.78B 531.1M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Celltrion KRW 779.18B 10.37B Jun/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Danaher USD 93.28B 914M Sep/2026
Dentsply International USD 5.19B 14M Sep/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Illumina USD 6.81B 162M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Laboratory Of America USD 18.92B 392.3M Sep/2026
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Mettler Toledo International USD 3.7B 24.53M Sep/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
OraSure Technologies USD 360.55M 18.62M Jun/2026
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Pharma Mar EUR 408.4M 14.8M Sep/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Quidel USD 5.78B 66M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Sartorius EUR 9.67B 70.9M Sep/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Tilray USD 2.1B 15.95M Sep/2025
Waters USD 24.12B 636M Sep/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026